Jennifer Blackmon
Family · Grants Pass, ORNPI 1417583642
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $263, 8.4 times the $31 reported in 2021.
Across 20 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$72
- Ascendis Pharma Endocrinology Inc$58
- Novo Nordisk$44
- Otsuka America Pharmaceutical, Inc.$36
- Recordati_rare_diseases_inc.$34
- Genentech USA, Inc.$31
- plus $137 from 6 others
What the payments were for
- Food & beverage$412100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $72 |
| Ascendis Pharma Endocrinology Inc | 3 | $58 |
| Novo Nordisk | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Recordati_rare_diseases_inc. | 2 | $34 |
| Genentech USA, Inc. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $24 |
| GSK | 1 | $22 |
| Mirum Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
How this compares
$412 in reported general payments places this provider in the 70th percentile of 1,130 family providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 27 | $590 |
| ProgesteroneProgesterone, Micronized | 11 | $466 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $293 |
| Cefdinir | 22 | $284 |
| Rosuvastatin Calcium | 12 | $278 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $223 |
| Levothyroxine Sodium | 15 | $176 |
| Doxycycline Hyclate | 11 | $128 |
| Montelukast Sodium | 11 | $105 |
| Ciprofloxacin Hcl | 21 | $99 |
| Levofloxacin | 21 | $95 |
| Azithromycin | 21 | $90 |
| Methylprednisolone | 11 | $89 |
| Prednisone | 18 | $44 |
Paid to pharmacies, not to this prescriber.
Other family in Grants Pass
- Nicole ParrottaGrants Pass$3K
- Laura JohnsonGrants Pass$3K
- Rachel PangilinanPortland$103K
- Jodeanna SweeneyCentral Point$45K
- Lani DoserPortland$45K
- David ArnopoleMedford$38K
- Heather HermanCorvallis$34K
- Amy BartramOregon City$33K
- Leah GaedekePortland$26K
- Bobbi Lee RothTualatin$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.